BBIO News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-17 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2026-08-10 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-07-22 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-07-02 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,3.02,3.03,5.03,7.01,9.01. |
| 2026-06-26 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02,5.07,9.01. |
| 2026-05-27 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-05-13 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-05-08 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,1.02,9.01. |
| 2026-05-07 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,8.01. |
| 2026-03-30 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-02-24 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-02-12 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-01-21 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03,3.02,8.01,9.01. |
| 2026-01-12 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,7.01,8.01,9.01. |
| 2025-10-29 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-10-29 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-10-27 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-08-05 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-07-02 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03. |
| 2025-06-23 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 3.03,5.03,5.07,9.01. |
| 2025-04-29 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-03-17 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2025-02-28 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,1.02,2.03,3.02,8.01,9.01. |
| 2025-02-20 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-01-13 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,7.01,8.01,9.01. |
| 2024-11-25 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-11-12 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-09-11 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-08-21 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-08-01 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-07-23 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2024-06-24 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.07,9.01. |
| 2024-06-06 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-05-02 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-03-06 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2024-03-04 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01. |
| 2024-02-22 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-01-18 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,1.02,2.03. |
| 2024-01-08 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-11-02 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-09-25 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01. |
| 2023-08-03 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-07-17 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2023-06-22 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.07,9.01. |
| 2023-05-04 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-05-04 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,1.02,9.01. |
| 2023-03-09 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2023-03-06 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2023-02-23 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,5.02,9.01. |
| 2022-12-06 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03,9.01. |
| 2022-11-03 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,8.01,9.01. |
| 2022-09-23 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2022-08-04 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,8.01,9.01. |
| 2022-07-26 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2022-06-24 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.07,9.01. |
| 2022-05-18 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03,8.01,9.01. |
| 2022-05-13 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2022-05-10 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-02-24 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-12-27 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2021-12-16 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.07. |
| 2021-11-18 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,1.02,2.03,8.01,9.01. |
| 2021-11-04 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-10-26 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2021-08-23 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2021-08-13 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-06-22 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.07. |
| 2021-06-01 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 9.01. |
| 2021-05-14 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-05-11 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01. |
| 2021-04-15 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03. |
| 2021-03-31 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01. |
| 2021-02-26 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-02-17 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2021-01-29 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03,3.02,8.01,9.01. |
| 2021-01-26 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.01,7.01,9.01. |
| 2021-01-26 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03,8.01,9.01. |
| 2021-01-20 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.07,8.01,9.01. |
| 2021-01-12 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01. |
| 2021-01-04 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02. |
| 2020-11-06 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.03,9.01. |
| 2020-11-05 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2020-10-23 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02. |
| 2020-10-06 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2020-10-05 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2020-09-29 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2020-08-11 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2020-06-24 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2020-06-08 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02,5.07. |
| 2020-05-13 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2020-04-29 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03. |
| 2020-03-24 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01. |
| 2020-03-10 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03,3.02,8.01,9.01. |
| 2020-03-06 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,2.03,8.01,9.01. |
| 2020-03-04 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 8.01. |
| 2020-03-02 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2020-02-19 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02. |
| 2020-01-07 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01. |
| 2019-12-26 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2019-12-17 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |